Join us on Monday, November 18th where David St. Denis, COO of Anteris Technologies will be contributing to Houston MedTech, an event that brings MedTech professionals to #Houston while highlighting what #Houston has to offer to those coming from out of town. Complimentary registration: https://lnkd.in/et6Y-Z8q The Basic Details... * Sponsor: Goodwin, Lifeblood & Mittal Consulting * Registration Form: https://lnkd.in/et6Y-Z8q * Date: Monday, November 18th 2024 * Time: 12:00 – 8:00pm (CDT) * Location: Levit Green, Houston, Texas * Maximum Capacity: 250 * Nearby hotel accommodations: --> Home2 Suites by Hilton Houston Medical Center, TX --> Hilton Garden Inn Houston Medical Center, TX THE AGENDA...Oh, and we have live music, drinx, and food * 12:00 – 12:20pm: Doors open for mingling * 12:20 – 12:30pm: Opening remarks: Martin Gomez, Giovanni Lauricella & Kristen Mittal, RAC, PMP * 1:00 - 2:00pm: Transatlantic MedTech CEO from Houston - The Art of a Deal: Andrew Glass * 1:00 – 2:00pm: How and Why Corporate Strategics Buy Startups?: Nick Benson, Jason Topolosky, David McDonough * 2:00 – 2:30pm: Crossing the Biotech-MedTech Chasm: David St. Denis * 2:30 – 2:45pm: Academindustry? Transitioning from Research to Business: Lindsey Cauthen, Ph.D. * 2:45 – 3:00pm: The 3B Model – From Bench to Business to Bedside: Maarten Rotman, Ph.D. * 3:00 – 3:15pm: Medical Device (MD) Anderson?: Jean K. Gilbert * 3:15 – 3:45PM: Regulatory Strategies Investors Need to Know: Kristen Mittal, RAC, PMP * 3:45 – 4:15pm: Freedom to Operate Isn’t Free…It’s Avoided? Martin Gomez * 4:15 – 5:15pm: What is Going on in MedTech Right Now – A View on Fundamentals and Capital Markets: David Roman * 5:15 – 5:30pm: Networking Break * 5:30 – 6:45pm: MedTech Stakeholders…The Full-Spectrum Perspective (See below for details) * 6:45 – 7:00pm: 2025 Outlook for MedTech in #Houston: Emily Reiser * 7:00 – 8:00pm: Networking with Drinx, Live Music, and Fire Places The panel details: MedTech Stakeholders…The Full-Spectrum Perspective * Moderator: (Houston) Giovanni Lauricella * Strategic Acquirer: (Illinois) David McDonough * FDA: (California) Kwame Ulmer * Entrepreneur: (Houston) Meagan R. Pitcher, Ph.D. * Physician: (Houston) Mas Takashima, MD, FACS, FAAOA * Board Member: (Arizona) Michael Nagel * Investor: (Houston) John Nghiem * Hospital Venture Arm: (North Carolina) Evan Bernath * Academic Research Partner: (Houston) Homer Quintana * Industry Partner: (Minnesota) Nathan Piland, M.Eng, MBA * Patient: (Houston) Cody Jorgensen You haven't registered already? There is 250 maximum spots to attend and as of today we are more than half spoken for. Giddy up...Complimentary registration: https://lnkd.in/et6Y-Z8q
MedTech Money
Medical Equipment Manufacturing
Demystifying raising and investing capital for MedTech.
About us
Let’s face it, raising capital for your MedTech startup is a grind. It has to be a grind. Here at MedTech Money we are hoping to make that process a little bit easier. Whether you are an experienced executive or new to the MedTech startup journey we think you will find value in our products and services. MedTech Money launched this month. We help entrepreneurs by providing curated insights and data relevant to your capital raise at an affordable price. Our website www.medtechmoney.com is currently in beta and we have products available for purchase and download right now. Our vision for the future is to build a community where MedTech entrepreneurs can come to MedTech Money for latest insights from industry leaders, curated and vetted service providers and data that is uniquely tailored for your MedTech startup needs. Thank you for checking out www.medtechmoney.com and we look forward to joining you on your incredible and important journey together. See you at MedTech Money!
- Industry
- Medical Equipment Manufacturing
- Company size
- 2-10 employees
- Headquarters
- United States
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Fundraising, Insights, Data, Lead Generation, MedTech, Medical Technologies, Digital Health, Medical Devices, In-vitro Diagnostics, Investment Banking, Venture Capital, Seed Funding, Crowd Funding, Startups, Entrepreneurship, and Finance
Locations
-
Primary
Get directions
United States , US
Updates
-
Only at "MedTech Malta" on 6-8 November: This panel brings together the numerous stakeholder perspectives on what it takes to build a MedTech company. Entrepreneurs, investors, physicians, corporate strategics, and industry partners come together. Find out why it takes a village to develop and commercialize medical technologies on "The Rock in the Mediterranean" next week in Malta! MedTech Malta is co-hosted by Giovanni Lauricella and Dylan Attard MD, MRCSI, MEnt. of Lifeblood and MedTech World... Check it out... * www.med-tech.world * www.lifeblood.com
"The MedTech Startup Equation" is about bringing together the numerous stakeholder perspectives on what it takes to build a MedTech company. Entrepreneurs, investors, physicians, corporate strategics, and industry partners come together to discuss how they contribute to building businesses and commercializing medical technologies. This panel is wealthy with stories of building MedTech companies from their own perspectives and will have the punch line as to why it takes a village of stakeholders to develop and commercialize medical technologies! A big thank you for coming to Malta for us and looking forward to seeing you on the Mediterranean Rock 6-8 November...THAT'S NEXT WEEK! Moderators: * Giovanni Lauricella, CEO of Lifeblood * Malek Nasr, Co-Founder of HighLife Panelists: Entrepreneurs * Anna Lisa Somera, CEO of Rhaeos Investors * Sanchita Pasi, Investor at EQT Life Sciences * Rik Vandevenne, Managing Director at RC Capital Corporate Strategics * Howard Hechler, President of Lumicell * David McDonough, President at Northgate Technologies Inc. Physicians * Austin Lee Chiang, MD MPH, Chief Medical Officer at Medtronic Endoscopy Industry Partners * Nathan Piland, M.Eng, MBA, Founder of Nunex With love for being in Malta with MedTech-ers, Giovanni Lauricella CEO of Lifeblood www.lifeblood.com
-
-
Only at "MedTech Malta" on 6-8 November: These serial MedTech entrepreneurs could making their own tequila like other rock stars and the famous do, instead their building their next MedTech Startup...why? Find out on "The Rock in the Mediterranean" next week in Malta! MedTech Malta is co-hosted by Giovanni Lauricella and Dylan Attard MD, MRCSI, MEnt. of Lifeblood and MedTech World... Check it out... * www.med-tech.world * www.lifeblood.com
"Serial Entrepreneurship in MedTech: Why We Continue?" Some call MedTech..."HardTech." And building one MedTech Startup is hard enough...these entrepreneurs keep doing it over and over. I want to find out why these entrepreneurs aren't on a beach sippin' margaritas or left the industry to go build a winery or jumped into crypto...and why they continue to build MedTech Startups. If you want a sneak peak into what Daniel Hawkins's theory is, check out this MedTech Money podcast that we did together in 2021...and he still keeps going: https://lnkd.in/eG6us_P4 This panel is wealthy with stories of building MedTech companies and will have the punch line as to why they continue to endure the game of "HardTech." A big thank you for coming to Malta for us and looking forward to seeing you on the Mediterranean Rock 6-8 November...THAT'S NEXT WEEK! Moderators: * Giovanni Lauricella, CEO of Lifeblood * Joseph Snyder, Principal of Lifeblood Panelists: * Daniel Hawkins, CEO of Vista.ai * Amir Gross, CEO of Cardiovalve * Youssef Biadillah, CEO of BariaTek * Tyler Wanke, CEO of Madison Scientific Inc * Anna Lisa Somera, CEO of Rhaeos With love for being in Malta with MedTech-ers, Giovanni Lauricella CEO of Lifeblood www.lifeblood.com
-
-
Lifeblood is retained on a U.S. Chief Commercialization Officer for a vascular startup that has $50M and is headquartered in Europe…see below for more and reach out to Giovanni Lauricella at [email protected]
U.S. Chief Commercialization Officer (CCO) Opportunity: This European, vascular, MedTech Startup has closed $50M in financing and is launching in The United States of America 🇺🇸. This CCO will be “THE FACE” of this company in the U.S. market and representing the European HQ! This video is live from the Washington Monument in DC during TCT as we gear up for “MedTech Malta” 🇲🇹 next week, which is taking place 6-8 November 2024 https://lnkd.in/excrRfQ6 On Monday, November 18th we are hosting Houston MedTech in the Texas Medical Center. Complimentary registration for this investor, strategic, and entrepreneur event is here https://lnkd.in/et6Y-Z8q Lifeblood is retained on this U.S. Chief Commercialization Opportunity that has multiple products launching in the market after raising a total of $50 million to-date. This European company is 100% focused on the largest market in the 🌎 and building its commercial team to execute a competitive product launch! What we need is a strategic commercial executive that is capable of designing the commercial strategy in parallel of regulatory clearance, building the commercial team, and enabling the commercial launch and story to resonate with the Board of Directors and future cross-over investors. Think of the commercial leaders for companies like Penumbra, Inc., Cardiovascular Systems, Inc., Shockwave Medical, Abiomed, Silk Road Medical, Inc., etc that built up meaningful commercial execution that enabled the company to exit (IPO or acquisition)…that’s the DNA 🧬 of profile that we need for this CCO. To save time…here are the minimum keys 🔑 to unlock 🔓 a conversation to learn more about this opportunity (see below). If you reach out and don’t hear back it’s because your key wasn’t working. Minimum experience… * Based in the U.S. * Vascular device commercialization experience * Capable of being the first commercial hire that can design, set, and execute the strategy for a product’s market entry and launch * Experience pitching commercial strategies to investors and boards of directors * Able to work in a MedTech Startup with limited resources and a fast paced environment - while reporting to the European HQ When you think of a U.S. CCO for a vascular company that can develop “the” commercial plan and execute on the market launch, who comes to mind? That’s who this position is for. Reach out to Giovanni Lauricella at [email protected] to learn more… With love for building European startup teams launching in the U.S, Giovanni Lauricella of Lifeblood The MedTech Industry's Global Recruitment and Advisory Firm www.lifeblood.com
-
Join us on Monday, November 18th where Emily Reiser, Strategy & New Venture at Texas Medical Center, will be contributing to Houston MedTech, an event that brings MedTech professionals to #Houston while highlighting what #Houston has to offer to those coming from out of town. Complimentary registration: https://lnkd.in/et6Y-Z8q The Basic Details... * Sponsor: Goodwin and Lifeblood * Registration Form: https://lnkd.in/et6Y-Z8q * Date: Monday, November 18th 2024 * Time: 12:00 – 8:00pm (CDT) * Location: Levit Green, Houston, Texas * Maximum Capacity: 250 * Nearby hotel accommodations: --> Home2 Suites by Hilton Houston Medical Center, TX --> Hilton Garden Inn Houston Medical Center, TX THE AGENDA...Oh, and we have live music, drinx, and food * 12:00 – 12:50pm: Doors open for mingling * 12:50 – 1:00pm: Opening remarks: Martin Gomez and Giovanni Lauricella * 1:00 – 2:00pm: How and Why Corporate Strategics Buy Startups?: Nick Benson, Jason Topolosky, David McDonough * 2:00 – 2:30pm: Crossing the Biotech-MedTech Chasm: David St. Denis * 2:30 – 2:45pm: Academindustry? Transitioning from Research to Business: Lindsey Cauthen, Ph.D. * 2:45 – 3:00pm: The 3B Model – From Bench to Business to Bedside: Maarten Rotman, Ph.D. * 3:00 – 3:15pm: Medical Device (MD) Anderson?: Jean K. Gilbert * 3:15 – 3:45PM: Freedom to Operate Isn’t Free…It’s Avoided? Martin Gomez * 3:45 – 4:00pm: Networking Break * 4:00 – 5:00pm: What is Going on in MedTech Right Now – A View on Fundamentals and Capital Markets: David Roman * 5:00 – 5:30pm: Networking Break * 5:30 – 6:45pm: MedTech Stakeholders…The Full-Spectrum Perspective (See below for details) * 6:45 – 7:00pm: 2025 Outlook for MedTech in #Houston: Emily Reiser * 7:00 – 8:00pm: Networking with Drinx, Live Music, and Fire Places The panel details: MedTech Stakeholders…The Full-Spectrum Perspective * Moderator: (Houston) Giovanni Lauricella * Strategic Acquirer: (Illinois) David McDonough * FDA: (California) Kwame Ulmer * Entrepreneur: (Houston) Meagan R. Pitcher, Ph.D. * Physician: (Houston) Mas Takashima, MD, FACS, FAAOA * Board Member: (Arizona) Michael Nagel * Investor: (Houston) John Nghiem * Hospital Venture Arm: (North Carolina) Evan Bernath * Academic Research Partner: (Houston) Homer Quintana * Industry Partner: (Minnesota) Nathan Piland, M.Eng, MBA * Patient: (Houston) Cody Jorgensen You haven't registered already? There is 250 maximum spots to attend and as of today we are more than half spoken for. Giddy up...Complimentary registration: https://lnkd.in/et6Y-Z8q
-
-
Lifeblood is retained on a U.S. Vice President of Clinical Affairs for a BCI (Brain-Computer Interface) company…see below for more and reach out to Giovanni Lauricella at [email protected]
VP of Clinical Affairs Opportunity: This BCI (Brain-Computer Interface) company has raised ~$100M worth of believers for the development of this generational technology that is at the crossroads of classically defined “medical devices,” deeptech, and human augmentation. This is a true “executive” position that is reporting to the CEO, presenting to the board of directors, and building a sizable team. This position will be a “Face” for the BCI industry to the FDA, the company, and our future as humans. Check out these articles and videos on BCI companies like Motif Neurotech (Houston shout out!), Blackrock Neurotech, INBRAIN Neuroelectronics, Neuralink, Paradromics Inc., Nia Therapeutics, Cognixion, etc. https://lnkd.in/eajPg9vU https://lnkd.in/e2cx3Sk4 https://lnkd.in/ePXCV7XS https://lnkd.in/eF7Jbw7q Lifeblood is retained on this U.S. Vice President of Clinical Affairs that will be tasked with designing and executing multiple clinical trials for arguably the most challenging medical device in human history. There is no such thing as a perfect candidate with relevant experience of getting a BCI through regulatory approval from achieving excellent clinical data from the design and execution of clinical trials. Why? BECAUSE THIS HAS NEVER BEEN DONE BEFORE! What we need is a polished clinical affairs professional who wants to take on the future, has experience with designing complex clinical trials for Class III electromechanical implantable medical devices, and isn’t afraid of being outward facing and reporting to an intense board of directors. To save time…here are the minimum keys 🔑 to unlock 🔓 a conversation to learn more about this opportunity (see below). If you reach out and don’t hear back it’s because your key wasn’t working. Minimum experience… * Based in the U.S. * Corporate MedTech experience * Ability to build and lead large teams * Experience with executing clinical trials for electromechanical medical device that have longterm patient follow up * Ability to travel 50% or more * Excellent oral and written communication and presentation skills When you think of a U.S. Vice President of Clinical Affairs that is capable of this much polish, industry exposure, and experience with complex devices and trials…that’s who we are looking for! Heck, think about the caliber of clinical affairs professional who has risen to CEO or GM like Lisa Wipperman Heine, Kate Rumrill or Tara Dunn! Reach out to Giovanni Lauricella at [email protected] to learn more… With love for recruiting clinical affairs executives tasked with changing the future of humans, Giovanni Lauricella of Lifeblood The MedTech Industry's Global Recruitment and Advisory Firm www.lifeblood.com
-
Join us on Monday, November 18th where David Roman, Managing Director of MedTech Global Investment Research for Goldman Sachs, will be contributing to Houston MedTech, an event that brings MedTech professionals to #Houston while highlighting what #Houston has to offer to those coming from out of town. Complimentary registration: https://lnkd.in/et6Y-Z8q The Basic Details... * Sponsor: Goodwin and Lifeblood * Registration Form: https://lnkd.in/et6Y-Z8q * Date: Monday, November 18th 2024 * Time: 12:00 – 8:00pm (CDT) * Location: Levit Green, Houston, Texas * Maximum Capacity: 250 * Nearby hotel accommodations: --> Home2 Suites by Hilton Houston Medical Center, TX --> Hilton Garden Inn Houston Medical Center, TX THE AGENDA...Oh, and we have live music, drinx, and food * 12:00 – 12:50pm: Doors open for mingling * 12:50 – 1:00pm: Opening remarks: Martin Gomez and Giovanni Lauricella * 1:00 – 2:00pm: How and Why Corporate Strategics Buy Startups?: Nick Benson, Jason Topolosky, David McDonough * 2:00 – 2:30pm: Crossing the Biotech-MedTech Chasm: David St. Denis * 2:30 – 2:45pm: Academindustry? Transitioning from Research to Business: Lindsey Cauthen, Ph.D. * 2:45 – 3:00pm: The 3B Model – From Bench to Business to Bedside: Maarten Rotman, Ph.D. * 3:00 – 3:15pm: Medical Device (MD) Anderson?: Jean K. Gilbert * 3:15 – 3:45PM: Freedom to Operate Isn’t Free…It’s Avoided? Martin Gomez * 3:45 – 4:00pm: Networking Break * 4:00 – 5:00pm: What is Going on in MedTech Right Now – A View on Fundamentals and Capital Markets: David Roman * 5:00 – 5:30pm: Networking Break * 5:30 – 6:45pm: MedTech Stakeholders…The Full-Spectrum Perspective (See below for details) * 6:45 – 7:00pm: 2025 Outlook for MedTech in #Houston: Emily Reiser * 7:00 – 8:00pm: Networking with Drinx, Live Music, and Fire Places The panel details: MedTech Stakeholders…The Full-Spectrum Perspective * Moderator: (Houston) Giovanni Lauricella * Strategic Acquirer: (Illinois) David McDonough * FDA: (California) Kwame Ulmer * Entrepreneur: (Houston) Meagan R. Pitcher, Ph.D. * Physician: (Houston) Mas Takashima, MD, FACS, FAAOA * Board Member: (Arizona) Michael Nagel * Investor: (Houston) John Nghiem * Hospital Venture Arm: (North Carolina) Evan Bernath * Academic Research Partner: (Houston) Homer Quintana * Industry Partner: (Minnesota) Nathan Piland, M.Eng, MBA * Patient: (Houston) Cody Jorgensen You haven't registered already? There is 250 maximum spots to attend and as of today we are more than half spoken for. Giddy up...Complimentary registration: https://lnkd.in/et6Y-Z8q
-
-
It is time to go back to "The Rock" in the Mediterranean! Lifeblood is going to MedTech Malta from 6-8 November. For those of you have already been...you may remember this: https://lnkd.in/eCXSUhdk For those of you who this will be your first "MedTech Malta" experience...get ready to live a MedTech networking experience that is a refreshing as Cisk www.cisk.com or as deep as Ta'Betta www.tabetta.com And if you have never seen the 1996 movie "The Rock" with Sean Connery...you are missing out almost as much as being in Malta on 6-8 November. Check out this epic trailer: https://lnkd.in/egkZNDCq MedTech World & Lifeblood are at it again in Valetta at the Mediterranean Conference Center https://mcc.com.mt/ bringing you a MedTech entrepreneur, investor, and community event that will leave you with a memory that for the rest of your life when someone says, "Malta," you will be like, "yes, I went to Malta for professional purposes that gave personal and pleasurable memories. And, yes I know where it is on the map now...and yes, I will be back in 2025." Malta...the prickly pear that has sweet juice. See you soon on 6 November! With great thanks to Dylan Attard MD, MRCSI, MEnt....the Mediterranean cowboy! Check out www.lifeblood.com - the MedTech talent recruitment & advisory firm
-
-
*Complimentary* MedTech Event on Monday, November 18th in Houston, Texas in the world's largest medical center of the Texas Medical Center. Creatively, this event is called: Houston MedTech Join us on Monday, November 18th for Houston MedTech, an event that brings MedTech professionals to #Houston while highlighting what #Houston has to offer to those coming from out of town. Complimentary registration: https://lnkd.in/et6Y-Z8q The Basic Details... * Sponsor: Goodwin and Lifeblood * Registration Form: https://lnkd.in/et6Y-Z8q * Date: Monday, November 18th 2024 * Time: 12:00 – 8:00pm (CDT) * Location: Levit Green, Houston, Texas * Maximum Capacity: 250 * Nearby hotel accommodations: --> Home2 Suites by Hilton Houston Medical Center, TX --> Hilton Garden Inn Houston Medical Center, TX THE AGENDA...Oh, and we have live music, drinks, and food * 12:00 – 12:50pm: Doors open for mingling * 12:50 – 1:00pm: Opening remarks: Martin Gomez and Giovanni Lauricella * 1:00 – 2:00pm: How and Why Corporate Strategics Buy Startups?: Nick Benson, Jason Topolosky, David McDonough * 2:00 – 2:30pm: Crossing the Biotech-MedTech Chasm: David St. Denis * 2:30 – 2:45pm: Academindustry? Transitioning from Research to Business: Lindsey Cauthen, Ph.D. * 2:45 – 3:00pm: The 3B Model – From Bench to Business to Bedside: Maarten Rotman, Ph.D. * 3:00 – 3:15pm: Medical Device (MD) Anderson?: Jean K. Gilbert * 3:15 – 3:45PM: Freedom to Operate Isn’t Free…It’s Avoided? Martin Gomez * 3:45 – 4:00pm: Networking Break * 4:00 – 5:00pm: What is Going on in MedTech Right Now – A View on Fundamentals and Capital Markets: David Roman * 5:00 – 5:30pm: Networking Break * 5:30 – 6:45pm: MedTech Stakeholders…The Full-Spectrum Perspective (See below for details) * 6:45 – 7:00pm: 2025 Outlook for MedTech in #Houston: Emily Reiser * 7:00 – 8:00pm: Networking with Drinx, Live Music, and Fire Places The panel details: MedTech Stakeholders…The Full-Spectrum Perspective * Moderator: (Houston) Giovanni Lauricella * Strategic Acquirer: (Illinois) David McDonough * FDA: (California) Kwame Ulmer * Entrepreneur: (Houston) Meagan R. Pitcher, Ph.D. * Physician: (Houston) Mas Takashima, MD, FACS, FAAOA * Board Member: (Arizona) Michael Nagel * Investor: (Houston) John Nghiem * Hospital Venture Arm: (North Carolina) Evan Bernath * Academic Research Partner: (Houston) Homer Quintana * Industry Partner: (Minnesota) Nathan Piland, M.Eng, MBA * Patient: (Houston) Cody Jorgensen You haven't registered already? There is 250 maximum spots to attend and as of today we are more than half spoken for. Giddy up...Complimentary registration: https://lnkd.in/et6Y-Z8q
-
-
Join us on Monday, November 18th where Nick Benson, Ex- Medtronic M&A and President of LifeTech Solutions, LLC, will be contributing to Houston MedTech, an event that brings MedTech professionals to #Houston while highlighting what #Houston has to offer to those coming from out of town. Complimentary registration: https://lnkd.in/et6Y-Z8q The Basic Details... * Sponsor: Goodwin and Lifeblood * Registration Form: https://lnkd.in/et6Y-Z8q * Date: Monday, November 18th 2024 * Time: 12:00 – 8:00pm (CDT) * Location: Levit Green, Houston, Texas * Maximum Capacity: 250 * Nearby hotel accommodations: --> Home2 Suites by Hilton Houston Medical Center, TX --> Hilton Garden Inn Houston Medical Center, TX THE AGENDA...Oh, and we have live music, drinks, and food * 12:00 – 12:50pm: Doors open for mingling * 12:50 – 1:00pm: Opening remarks: Martin Gomez and Giovanni Lauricella * 1:00 – 2:00pm: How and Why Corporate Strategics Buy Startups?: Nick Benson, Jason Topolosky, David McDonough * 2:00 – 2:30pm: Crossing the Biotech-MedTech Chasm: David St. Denis * 2:30 – 2:45pm: Academindustry? Transitioning from Research to Business: Lindsey Cauthen, Ph.D. * 2:45 – 3:00pm: The 3B Model – From Bench to Business to Bedside: Maarten Rotman, Ph.D. * 3:00 – 3:15pm: Medical Device (MD) Anderson?: Jean K. Gilbert * 3:15 – 3:45PM: Freedom to Operate Isn’t Free…It’s Avoided? Martin Gomez * 3:45 – 4:00pm: Networking Break * 4:00 – 5:00pm: What is Going on in MedTech Right Now – A View on Fundamentals and Capital Markets: David Roman * 5:00 – 5:30pm: Networking Break * 5:30 – 6:45pm: MedTech Stakeholders…The Full-Spectrum Perspective (See below for details) * 6:45 – 7:00pm: 2025 Outlook for MedTech in #Houston: Emily Reiser * 7:00 – 8:00pm: Networking with Drinx, Live Music, and Fire Places The panel details: MedTech Stakeholders…The Full-Spectrum Perspective * Moderator: (Houston) Giovanni Lauricella * Strategic Acquirer: (Illinois) David McDonough * FDA: (California) Kwame Ulmer * Entrepreneur: (Houston) Meagan R. Pitcher, Ph.D. * Physician: (Houston) Mas Takashima, MD, FACS, FAAOA * Board Member: (Arizona) Michael Nagel * Investor: (Houston) John Nghiem * Hospital Venture Arm: (North Carolina) Evan Bernath * Academic Research Partner: (Houston) Homer Quintana * Industry Partner: (Minnesota) Nathan Piland, M.Eng, MBA * Patient: (Houston) Cody Jorgensen You haven't registered already? There is 250 maximum spots to attend and as of today we are more than half spoken for. Giddy up...Complimentary registration: https://lnkd.in/et6Y-Z8q
-